Yazla, E. Et Al. 2022. Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology , vol.20, no.3 , 504-513.

Yazla, E., Kayadibi, H., Cetin, I., Aydinoglu, U., & Karadere, M. E., (2022). Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology , vol.20, no.3, 504-513.

Yazla, Ece Et Al. "Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.," Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology , vol.20, no.3, 504-513, 2022

Yazla, Ece Et Al. "Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology , vol.20, no.3, pp.504-513, 2022

Yazla, E. Et Al. (2022) . "Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology , vol.20, no.3, pp.504-513.

@article{article, author={Ece Yazla Et Al. }, title={Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.}, journal={Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology}, year=2022, pages={504-513} }